Civetta Therapeutics
Initial Transaction Details
Transaction Date
February 2019
Purpose of Financing
Venture
Stage of Company
Seed/Startup
Structure of Financing
Debt and Equity
Civetta is a biotechnology company focused on the development of therapies that target betapropeller domains to treat cancer and other diseases. The company was founded based on the pivotal insights into beta-propeller domains made by its founders, which helped elucidate betapropeller domain functionality and their potential for therapeutic intervention in oncology as well as neurodegeneration, metabolic disease and other disease areas. Civetta is funded by Deerfield Management Company and is based in Cambridge, MA.
Website